Patent · US Active

Peptides and peptide/active compound conjugates for renal targeting

US10065993B2 · kind B2 · utility

3Cited by

7References

20Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Armin Kuebelbeck · Bensheim, DE
Gregor Larbig · Gelnhausen, DE
Stefan Arnold · Munster, DE
Walter Mier · Bensheim, DE

Key dates

Filing date	Apr 16, 2014
Grant date	Sep 4, 2018
Priority date	—
Expiry date	Apr 16, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a peptide which consists of more than 50% of sequence sections of the formula -(An-Bm-Co)-, and to a conjugate containing the peptide and at least one covalently bonded active compound, and to a process for the preparation of the conjugate. The present invention furthermore relates to the use of the peptide and the conjugate for targeting of the kidney, and to a medicament comprising the peptide or conjugate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.